ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,688, issued on June 10, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).
"Gingerenone a prodrugs as sensotherapeutics and methods of use" was invented by Ruin Moaddel (Bel Air, Md.), Luigi Ferrucci (Baltimore), Kotb Abdelmohsen (Nottingham, Md.), Myriam Gorospe (Elliot City, Md.), Martina Rossi (Baltimore), Christopher E. Ramsden (Bethesda, Md.) and Gregory S. Keyes (Timonium, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Gingerenone A prodrug compounds have a structure according to Formula I, or a pharmaceutically acceptable salt thereof wherein one of R1 an...